PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION AND ASSOCIATION WITH SURVIVAL IN MESOTHELIOMA

被引：0
|
作者：
Mansfield, A. S. [1 ]
Peikert, T. [1 ]
Roden, A. [1 ]
Krco, C. [1 ]
Harrington, S. [1 ]
Dong, H. [1 ]
Kwon, E. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127O
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [21] Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nakashima, Kazutaka
    Shimono, Joji
    Hashiguchi, Toshihiro
    Mitsuoka, Masahiro
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    CLINICAL CANCER RESEARCH, 2016, 22 (18) : 4727 - 4734
  • [22] Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type
    Jo, Jae-Cheol
    Kim, Misung
    Choi, Yunsuk
    Kim, Hyun-Jung
    Kim, Ji Eun
    Chae, Seoung Wan
    Kim, Hawk
    Cha, Hee Jeong
    ANNALS OF HEMATOLOGY, 2017, 96 (01) : 25 - 31
  • [23] Expression of Programmed Cell Death 1 and Programmed Cell Death Ligand 1 in Extranodal NK/T-Cell Lymphoma, Nasal Type
    Jo, Jae-Cheol
    Choi, Yunsuk
    Cha, Hee Jeong
    Lee, Eun Hee
    Kang, Eun Kyoung
    Kim, Hawk
    BLOOD, 2015, 126 (23)
  • [24] Programmed Cell Death 1 Ligand 1 (PD-L1) Expression in Thymoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nishi, Tatsuya
    Matsumoto, Ryouichi
    Hashiguchi, Toshihiro
    Murakami, Daigo
    Kashihara, Masaki
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S503 - S503
  • [25] Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type
    Jae-Cheol Jo
    Misung Kim
    Yunsuk Choi
    Hyun-Jung Kim
    Ji Eun Kim
    Seoung Wan Chae
    Hawk Kim
    Hee Jeong Cha
    Annals of Hematology, 2017, 96 : 25 - 31
  • [26] Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
    Yu Wei-Bo
    Rao Jian-Yu
    慢性疾病与转化医学（英文）, 2019, 5 (03) : 170 - 177
  • [27] Assessment of programmed cell death 1 and its programmed cell death ligand 1 levels in vitiligo
    Nada, Hanan R.
    Mourad, Ahmed
    Rashed, Laila A.
    El-Hanafy, Ghada M.
    Abdallah, Nermeen M. A.
    Abdelhady, Mohamed M.
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2025, 22 (01): : 79 - 87
  • [28] Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma
    Hanna, Glenn J.
    Kacew, Alec J.
    Tanguturi, Anusha R.
    Grote, Hans J.
    Vergara, Victoria
    Brunkhorst, Beatrice
    Rabinowits, Guilherme
    Thakuria, Manisha
    LeBoeuf, Nicole R.
    Ihling, Christian
    DeCaprio, James A.
    Lorch, Jochen H.
    FRONTIERS IN MEDICINE, 2020, 7
  • [29] Association between programmed cell death ligand 1 expression and thyroid cancer A meta-analysis
    Wan, Baoyu
    Deng, Pengyi
    Dai, Wenli
    Wang, Peng
    Dong, Zhizhi
    Yang, Chaojun
    Tian, Jinling
    Hu, Tao
    Yan, Kai
    MEDICINE, 2021, 100 (14)
  • [30] Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
    Pezeshki, Parmida Sadat
    Mahdavi Sharif, Pouya
    Rezaei, Nima
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1575 - 1590
12345